{
    "meta": {
      "totalResults": 2,
      "from": 0
    },
    "results": [
      {
        "aliases": [
          {
            "type": "Abbreviation",
            "name": "GM-CSF BREAST VAC"
          }
        ],
        "definition": {
          "html": "An allogenic vaccine consisting of irradiated breast cancer cells transfected with the granulocyte macrophage-colony-stimulating factor (GM-CSF) gene. Upon vaccination, the genetically modified cells secrete GM-CSF, thereby potentiating  a tumor-specific T cell response against breast cancer cell-asociated antigens.",
          "text": "An allogenic vaccine consisting of irradiated breast cancer cells transfected with the granulocyte macrophage-colony-stimulating factor (GM-CSF) gene. Upon vaccination, the genetically modified cells secrete GM-CSF, thereby potentiating  a tumor-specific T cell response against breast cancer cell-asociated antigens."
        },
        "drugInfoSummaryLink": null,
        "nciConceptId": "C48371",
        "nciConceptName": "Allogeneic GM-CSF-Secreting Breast Cancer Vaccine",
        "termId": 392723,
        "name": "allogeneic GM-CSF-secreting breast cancer vaccine",
        "firstLetter": "a",
        "type": "DrugTerm",
        "termNameType": "PreferredName",
        "prettyUrlName": "allogeneic-gm-csf-secreting-breast-cancer-vaccine"
      },
      {
        "aliases": [
          {
            "type": "Synonym",
            "name": "SV-BR-1-GM"
          },
          {
            "type": "Synonym",
            "name": "SV-BR-1 breast cancer cell line vaccine"
          },
          {
            "type": "Synonym",
            "name": "SV-BR-1-GM vaccine"
          },
          {
            "type": "USBrandName",
            "name": "Bria-IMT"
          },
          {
            "type": "Synonym",
            "name": "GM-CSF gene-transfected breast cancer vaccine SV-BR-1-GM"
          },
          {
            "type": "Synonym",
            "name": "SV-BR1-GM breast cancer vaccine"
          }
        ],
        "definition": {
          "html": "A vaccine consisting of irradiated allogeneic breast cancer cells, derived from the breast cancer cell line SV-BR-1 that are transfected with the immunostimulant granulocyte-macrophage colony-stimulating factor (GM-CSF; CSF2) gene, with potential immunostimulating and antineoplastic activities. Upon intradermal administration of the allogeneic GM-CSF-secreting breast cancer vaccine SV-BR-1-GM, the genetically-modified cells secrete GM-CSF. This potentiates a tumor-specific cytotoxic T-lymphocyte (CTL) immune response against breast cancer cells.",
          "text": "A vaccine consisting of irradiated allogeneic breast cancer cells, derived from the breast cancer cell line SV-BR-1 that are transfected with the immunostimulant granulocyte-macrophage colony-stimulating factor (GM-CSF; CSF2) gene, with potential immunostimulating and antineoplastic activities. Upon intradermal administration of the allogeneic GM-CSF-secreting breast cancer vaccine SV-BR-1-GM, the genetically-modified cells secrete GM-CSF. This potentiates a tumor-specific cytotoxic T-lymphocyte (CTL) immune response against breast cancer cells."
        },
        "drugInfoSummaryLink": null,
        "nciConceptId": "C146711",
        "nciConceptName": "Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM",
        "termId": 792158,
        "name": "allogeneic GM-CSF-secreting breast cancer vaccine SV-BR-1-GM",
        "firstLetter": "a",
        "type": "DrugTerm",
        "termNameType": "PreferredName",
        "prettyUrlName": "allogeneic-gm-csf-secreting-breast-cancer-vaccine-sv-br-1-gm"
      }
    ],
    "links": null
  }